Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin J Cullen

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Cell Death Discovery|May 22, 2020
Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinomaZejia Yang, Jipei Liao, Kevin J Cullen, et al.
The Journal of Bone and Joint Surgery. American Volume|July 11, 2002
A happy outcome to a bad problemHenry J Mankin, Keith B Isaacson, Kevin J Cullen
Journal of Bioenergetics and Biomembranes|February 24, 2007
Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancerKevin J Cullen, Zejia Yang, Lisa Schumaker, et al.
CA: a Cancer Journal for Clinicians|December 22, 2012
The role of human papillomavirus in nongenital cancersDan P Zandberg, Ranjana Bhargava, Simon Badin, et al.
Journal of Comparative Effectiveness Research|May 11, 2022
Cost-effectiveness of concurrent radiation with cetuximab or chemotherapy in older patients with oropharyngeal cancerHusam Albarmawi, Kevin J Cullen, Ranee Mehra, et al.
Head & Neck|March 2, 2024
Differential modulation of PI3K/Akt/mTOR activity by EGFR inhibitors: A rationale for co-targeting EGFR and PI3K in cisplatin-resistant HNSCCJipei Liao, Zejia Yang, Shirin Azarbarzin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Capecitabine induces rapid, sustained response in two patients with extensive oral verrucous carcinomaAnastasios Salesiotis, Richie Soong, Robert B Diasio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Elevated expression of glutathione S-transferase pi and p53 confers poor prognosis in head and neck cancer patients treated with chemoradiotherapy but not radiotherapy aloneLisa Schumaker, Nikolaos Nikitakis, Olga Goloubeva, et al.
British Journal of Haematology|November 28, 2008
Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosisMark A Scheper, Ashraf Badros, Risa Chaisuparat, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 12, 2014
Emergence of HPV16-positive oropharyngeal cancer in Black patients over time: University of Maryland 1992-2007Dan P Zandberg, Sandy Liu, Olga G Goloubeva, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Cell Death Discovery|May 22, 2020
Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinomaZejia Yang, Jipei Liao, Kevin J Cullen, et al.
The Journal of Bone and Joint Surgery. American Volume|July 11, 2002
A happy outcome to a bad problemHenry J Mankin, Keith B Isaacson, Kevin J Cullen
Journal of Bioenergetics and Biomembranes|February 24, 2007
Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancerKevin J Cullen, Zejia Yang, Lisa Schumaker, et al.
CA: a Cancer Journal for Clinicians|December 22, 2012
The role of human papillomavirus in nongenital cancersDan P Zandberg, Ranjana Bhargava, Simon Badin, et al.
Journal of Comparative Effectiveness Research|May 11, 2022
Cost-effectiveness of concurrent radiation with cetuximab or chemotherapy in older patients with oropharyngeal cancerHusam Albarmawi, Kevin J Cullen, Ranee Mehra, et al.
Head & Neck|March 2, 2024
Differential modulation of PI3K/Akt/mTOR activity by EGFR inhibitors: A rationale for co-targeting EGFR and PI3K in cisplatin-resistant HNSCCJipei Liao, Zejia Yang, Shirin Azarbarzin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Capecitabine induces rapid, sustained response in two patients with extensive oral verrucous carcinomaAnastasios Salesiotis, Richie Soong, Robert B Diasio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Elevated expression of glutathione S-transferase pi and p53 confers poor prognosis in head and neck cancer patients treated with chemoradiotherapy but not radiotherapy aloneLisa Schumaker, Nikolaos Nikitakis, Olga Goloubeva, et al.
British Journal of Haematology|November 28, 2008
Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosisMark A Scheper, Ashraf Badros, Risa Chaisuparat, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 12, 2014
Emergence of HPV16-positive oropharyngeal cancer in Black patients over time: University of Maryland 1992-2007Dan P Zandberg, Sandy Liu, Olga G Goloubeva, et al.
Pageof 6